It is a pharma private limited company based in Secunderabad, Telangana, India, established in 2018.
2018 | Secunderabad, Telangana, India | ActiveMedivast Pharmatech Private Limited, a active private limited company, was established on 27 November 2018 in Secunderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51909TG2018PTC128562. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Kavitha Manoji Jagathkar (Director), Ganshyam Manoji Jagathkar (Director). Past directors included Rama Lakshmi Gorti, Narsimhachary Praveena Upadhyaya, Aleyamma Joseph. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 2-4-29/30 Tnr Enclave Anjana Puri Colony, Alwal, Secunderabad, Telangana, 500010.
U51909TG2018PTC128562
128562
27 November 2018
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Medivast Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kavitha Manoji Jagathkar | Director | 27 Nov 2018 | Current |
| Ganshyam Manoji Jagathkar | Director | 27 Nov 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Mar 2021 | Past |
| Pramod Abcsdd | Director | 31 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 01 Feb 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medivast Pharmatech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 412.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Medivast Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medivast Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medivast Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medivast Pharmatech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medivast Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Medivast Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.
The activity Kavitha Manoji Jagathkar was appointed as a Director was appointed as a Director on 27 Nov 2018 & has been associated with this company since 7 years 21 days . was completed.
Ganshyam Manoji Jagathkar was appointed as a Director was appointed as a Director on 27 Nov 2018 & has been associated with this company since 7 years 21 days . was recorded as a recent event.
The activity Medivast Pharmatech Private Limited was registered on 27 Nov 2018 with Roc Hyderabad & aged 7 years 21 days as per MCA records. was completed.
The CIN of Medivast Pharmatech Private Limited is U51909TG2018PTC128562.
Medivast Pharmatech Private Limited is headquartered at 2-4-29/30 Tnr Enclave Anjana Puri Colony, Alwal, Secunderabad, Telangana, 500010.
Medivast Pharmatech Private Limited was incorporated on 27 November 2018.
The current directors of Medivast Pharmatech Private Limited are
The primary industry of Medivast Pharmatech Private Limited is Pharma.
Medivast Pharmatech Private Limited is unlisted.
The authorized capital of Medivast Pharmatech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX